Overview

Study of Pamidronate for the Prevention of Heterotopic Ossification

Status:
Withdrawn
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Bisphosphonates in comparison to radiation therapy are effective in the prophylaxis and treatment of heterotopic ossification in high risk patients.
Phase:
N/A
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborator:
FAG (Freie Medizinische Gesellschaft)
Treatments:
Pamidronate